Pinion Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Pinion Investment Advisors's BMY Position: Q2 2026 in Review
Pinion Investment Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,158 shares worth $240K. The stake represents 0.05% of the portfolio and ranks #189 among its holdings. This is a return to the name: Pinion Investment Advisors previously reported a position in BMY as recently as Q2 2021.
Pinion Investment Advisors first reported a position in BMY in Q2 2020 and has held it in 6 quarters since. The position peaked at $320K in Q3 2020. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Pinion Investment Advisors held 4,158 shares of Bristol-Myers Squibb worth $240K as of Q2 2026.
- Bristol-Myers Squibb was a new Pinion Investment Advisors position in Q2 2026.
- Bristol-Myers Squibb made up 0.05% of Pinion Investment Advisors's portfolio in Q2 2026, its #189 holding.
- Pinion Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 6 quarters since.
- Pinion Investment Advisors's Bristol-Myers Squibb position peaked at $320K in Q3 2020.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Pinion Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.